跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 713 条关于
“FabI”
全部
713
临床试验
477
药物
123
机构
26
资讯
87
8个月前
GARDP and Debiopharm Partner to Develop Novel First-in-Class Antibiotic for Multidrug-Resistant Gonorrhea
去年
CARB-X Awards Debiopharm Additional $12.3 Million to Advance Novel Antibiotic Debio 1453 Against Drug-Resistant Gonorrhea
2年前
Precision Medicine and Clinical Trials Improve Breast Cancer Survivorship
7个月前
Teva Canada Partners with Novartis to Commercialize Multiple Sclerosis Treatment Mayzent
去年
HepaRegeniX Secures €15 Million to Advance HRX-215 for Liver Regeneration
3个月前
The Tumor Microenvironment as a Driver of Disease Progression and Therapeutic Response in Gynecological Malignancies
去年
HepaRegeniX Secures €15 Million to Advance HRX-215 for Liver Regeneration
2年前
HepaRegenix Secures €15 Million to Advance HRX-215 Liver Regeneration Therapy
25天前
Cellares to Lay Off 100 Employees After Losing Large Cell Therapy Manufacturing Partner
去年
PharmaTher on Track for Ketamine FDA Resubmission, Anticipates Q2 2025 Approval
第 1 页,共 9 页
上一页
下一页